8-K: Arteris Reports Record ACV Plus Royalties and Positive Free Cash Flow for Q3 2024, Issues Q4 and Full Year Guidance

Arteris announced record Annual Contract Value plus royalties of $60.5 million and its third consecutive quarter of positive free cash flow in Q3 2024, along with Q4 and full year 2024 guidance.

Summary

• Arteris reported a revenue of $14.7 million for the third quarter of 2024.
• The company achieved a record Annual Contract Value (ACV) plus royalties of $60.5 million, a 6% increase year-over-year.
• Remaining performance obligation (RPO) reached $78.4 million, a 25% increase year-over-year, marking the highest level ever reported.
• Arteris generated positive non-GAAP free cash flow of $1.1 million, representing 7% of revenue.
• The operating loss was $7.9 million, an improvement from the $8.5 million loss in the same period last year.
• Non-GAAP operating loss was $3.3 million, compared to a $4.5 million loss in the prior year.
• The net loss was $7.7 million, or $0.20 per share.
• Non-GAAP net loss was $3.1 million, or $0.08 per share.
• For the fourth quarter of 2024, Arteris projects ACV plus royalties between $63.0 and $67.0 million, revenue between $14.7 and $15.7 million, non-GAAP operating loss between $4.0 and $5.0 million, and free cash flow between -$0.9 and $1.1 million.
• For the full year 2024, Arteris anticipates ACV plus royalties between $63.0 and $67.0 million, revenue between $56.9 and $57.9 million, non-GAAP operating loss between $16.1 and $17.1 million, and free cash flow between $0.7 and $2.7 million.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with record ACV and positive free cash flow, but the continued net losses and potential for negative free cash flow in Q4 temper the overall sentiment. The company is showing growth and strategic expansion, but still has some financial challenges to overcome.

Positives

• The company achieved record ACV plus royalties, indicating strong sales performance.
• Positive free cash flow for the third consecutive quarter suggests improved financial health.
• The significant increase in RPO demonstrates strong future revenue potential.
• Expansion into the microcontroller market diversifies the company's customer base.
• The addition of NoC tiling enhances the company's product offerings.
• New partnerships and customer wins highlight the company's growing market presence.
• The appointment of new board and executive members could bring fresh perspectives and expertise.

Negatives

• The company reported an operating loss of $7.9 million, although it is an improvement year-over-year.
• Arteris experienced a net loss of $7.7 million, or $0.20 per share.
• The company's guidance for Q4 2024 indicates a potential for negative free cash flow.

Risks

• The company faces significant competition from larger companies and third-party providers.
• Arteris has a history of net losses.
• The company's success depends on the adoption of its solutions by semiconductor companies in various markets.
• The company's ability to sustain or grow licensing revenue is crucial.
• Macro-economic conditions and geopolitical conflicts could adversely impact the company.
• The company is exposed to regulatory, operational, financial, and political risks due to its international operations.
• There is a risk of product errors or defects in the company's solutions.
• The company's reliance on international customers and operations exposes it to various risks.

Future Outlook

Arteris provided guidance for Q4 2024 and full year 2024, projecting ACV plus royalties between $63.0 and $67.0 million, revenue between $14.7 and $15.7 million for Q4 and $56.9 and $57.9 million for the full year, non-GAAP operating loss between $4.0 and $5.0 million for Q4 and $16.1 and $17.1 million for the full year, and free cash flow between -$0.9 and $1.1 million for Q4 and $0.7 and $2.7 million for the full year.

Management Comments

• K. Charles Janac, President and CEO of Arteris, stated they were excited to report a record $60.5 million in Annual Contract Value plus royalties and their third consecutive quarter of positive free cash flow.
• Janac noted the increasing traction with some of the largest customers in the market, particularly top 30 technology companies.
• Janac concluded that the industry need for Arteris' high-performance commercial System IP solutions has continued to increase.

Industry Context

The announcement highlights Arteris' position in the system IP market, particularly in the context of increasing demand for high-performance and energy-efficient SoCs in sectors like automotive, enterprise computing, and AI. The expansion into microcontrollers also reflects a broader trend of integrating advanced technology into a wider range of devices.

Comparison to Industry Standards

• Arteris's 6% year-over-year growth in ACV plus royalties is a positive sign, but it is important to compare this to the growth rates of its direct competitors such as Cadence Design Systems and Synopsys, who also provide similar IP solutions.
• The 25% year-over-year increase in RPO is a strong indicator of future revenue, and this should be compared to the RPO growth of other companies in the semiconductor IP space.
• The positive free cash flow is a positive development, but it is important to assess the sustainability of this trend and compare it to the cash flow performance of other companies in the industry.
• The operating and net losses, while improving year-over-year, still need to be monitored closely and compared to the profitability of other companies in the sector, such as ARM Holdings, which is a major player in the IP market.
• The expansion into microcontrollers is a strategic move that could open up new markets for Arteris, but it is important to see how this compares to the strategies of other companies in the embedded systems market.

Management Changes

Stakeholder Impact

• Shareholders may view the record ACV and positive free cash flow as positive indicators of the company's performance.
• Employees may be encouraged by the company's growth and strategic expansion.
• Customers may benefit from the company's expanded product offerings and partnerships.
• Suppliers may see increased business opportunities with the company's growth.
• Creditors may view the positive free cash flow as a sign of improved financial stability.

Next Steps

• Arteris will host a conference call on November 5, 2024, to review its third quarter 2024 financial results and discuss its financial outlook.
• The company will file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, with the SEC on November 5, 2024.

Key Dates

Keywords

System IP, SoC, Interconnect IP, Network-on-Chip, Semiconductor, Annual Contract Value, Free Cash Flow, Microcontrollers, AI SoCs, RISC-V, Chiplets